Literature DB >> 3976699

Patterns of foot examination in a diabetes clinic.

T S Bailey, H M Yu, E J Rayfield.   

Abstract

Peripheral vascular disease is a well-known source of morbidity and potential mortality in diabetic patients. Sixty-five subjects with diabetes were studied in order to describe the contributions of the patient, the physician, and the health care system to the performance of a preventive foot examination. The incidences of foot examination on the day of study (12.3 percent) and during the previous year (49.2 percent) were similar to those found by other investigators. The feet of patients at higher risk for limb amputation were not examined with greater frequency at the clinic, although such patients were more often referred to a podiatrist. The most significant determinants of physician foot examination were patient recall of foot-related education received at the clinic and inter-physician variability. These data suggest that the patient, physician, and clinic routine all play an important role in the success of a foot screening program for patients with diabetes.

Entities:  

Mesh:

Year:  1985        PMID: 3976699     DOI: 10.1016/0002-9343(85)90326-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  9 in total

1.  In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.

Authors:  Ellie J C Goldstein; Diane M Citron; Yumi A Warren; Kerin L Tyrrell; C Vreni Merriam; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.

Authors:  F de Lalla; G Pellizzer; M Strazzabosco; Z Martini; G Du Jardin; L Lora; P Fabris; P Benedetti; G Erle
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 3.  Diabetic foot ulcers. Pathophysiology, assessment, and therapy.

Authors:  C K Bowering
Journal:  Can Fam Physician       Date:  2001-05       Impact factor: 3.275

4.  Effect of a physician-directed educational campaign on performance of proper diabetic foot exams in an outpatient setting.

Authors:  Kevin E O'Brien; Vineeth Chandramohan; Douglas A Nelson; Joseph R Fischer; Gary Stevens; John A Poremba
Journal:  J Gen Intern Med       Date:  2003-04       Impact factor: 5.128

5.  In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

Review 6.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

7.  Funduscopic examination of patients with diabetes who are admitted to hospital.

Authors:  A L Edwards
Journal:  CMAJ       Date:  1986-06-01       Impact factor: 8.262

8.  Foot deformities, function in the lower extremities, and plantar pressure in patients with diabetes at high risk to develop foot ulcers.

Authors:  Ulla Hellstrand Tang; Roland Zügner; Vera Lisovskaja; Jon Karlsson; Kerstin Hagberg; Roy Tranberg
Journal:  Diabet Foot Ankle       Date:  2015-06-17

9.  Nurses' role in diabetic foot prevention and care; a review.

Authors:  M Aalaa; O Tabatabaei Malazy; M Sanjari; M Peimani; Mr Mohajeri-Tehrani
Journal:  J Diabetes Metab Disord       Date:  2012-11-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.